Open AccessBest practices: Appropriate use of the new β-lactam/β-lactamase inhibitor combinations, ceftazidime-avibactam and ceftolozane-tazobactam in South Africa
Author(s) -
Adrian Brink,
Jennifer Coetzee,
Guy A. Richards,
Charles Feldman,
Warren Lowman,
Hafsah Deepa Tootla,
Malcolm Miller,
Abraham J. Niehaus,
Sean Wasserman,
Olga Perovic,
Chetna Govind,
Natalie Schellack,
Marc Mendelson
Publication year - 2022
Publication title -
southern african journal of infectious diseases
Language(s) - English
Resource type - Journals
eISSN - 2313-1810
pISSN - 2312-0053
DOI - 10.4102/sajid.v37i1.453
Subject(s) - ceftazidime/avibactam , colistin , antibiotics , intensive care medicine , avibactam , medicine , stewardship (theology) , ceftazidime , tazobactam , drug resistance , antibiotic resistance , microbiology and biotechnology , biology , pseudomonas aeruginosa , bacteria , genetics , imipenem , politics , law , political science